BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2228430)

  • 1. Babesia bovis: immunity induced by vaccination with a lipid enriched fraction.
    Goodger BV; Commins MA; Waltisbuhl DJ; Wright IG; Rode-Bramanis K
    Int J Parasitol; 1990 Aug; 20(5):685-7. PubMed ID: 2228430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Babesia bovis: dextran sulphate as an adjuvant for and precipitant of protective immunogens.
    Goodger BV; Waltisbuhl DJ; Commins MA; Wright IG
    Int J Parasitol; 1992 Jul; 22(4):465-9. PubMed ID: 1644521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful homologous vaccination against Babesia bovis using a heparin-binding fraction of infected erythrocytes.
    Goodger BV; Commins MA; Wright IG; Waltisbuhl DJ; Mirre GB
    Int J Parasitol; 1987 Apr; 17(4):935-40. PubMed ID: 3583543
    [No Abstract]   [Full Text] [Related]  

  • 4. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tick and blood challenge for assessing immunity to Babesia bovis.
    Timms P; Stewart NP; Dalgliesh RJ
    Aust Vet J; 1983 Aug; 60(8):257-9. PubMed ID: 6639533
    [No Abstract]   [Full Text] [Related]  

  • 6. Attenuation of Babesia bovis by in vitro cultivation.
    Yunker CE; Kuttler KL; Johnson LW
    Vet Parasitol; 1987 Apr; 24(1-2):7-13. PubMed ID: 3590611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Babesia bovis: vaccination studies with three groups of high molecular weight antigens from lysate of infected erythrocytes.
    Waltisbuhl DJ; Goodger BV; Wright IG; Mirre GB; Commins MA
    Parasitol Res; 1987; 73(4):319-23. PubMed ID: 3303020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine babesiosis: induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens.
    Montenegro-James S; Toro Benitez M; Leon E; Lopez R; Ristic M
    Parasitol Res; 1987; 74(2):142-50. PubMed ID: 3325981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenicity and immunologic relationship of a virulent and a tissue-culture-adapted Babesia bovis.
    Kuttler KL; Zaugg JL; Yunker CE
    Vet Parasitol; 1988 Mar; 27(3-4):239-44. PubMed ID: 3285573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen.
    Montenegro-James S; Ristic M; Toro Benitez M; Leon E; Lopez R
    Vet Parasitol; 1985 Dec; 18(4):321-37. PubMed ID: 4090242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity in cattle to Babesia bovis after single infections with parasites of various origin.
    Mahoney DF; Wright IG; Goodger BV
    Aust Vet J; 1979 Jan; 55(1):10-2. PubMed ID: 435202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Babesia bovis: the effect of acute inflammation and isoantibody production in the detection of babesial antigens.
    Goodger BV; Wright IG; Waltisbuhl DJ
    Experientia; 1985 Dec; 41(12):1577-9. PubMed ID: 4076403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Babesial antigens in a saline eluate of sucrose washed bovine erythrocytes infected with Babesia bovis.
    Goodger BV; Wright IG
    Experientia; 1983 Dec; 39(12):1392-3. PubMed ID: 6360707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a highly infective Babesia bigemina vaccine of reduced virulence.
    Dalgliesh RJ; Callow LL; Mellors LT; McGregor W
    Aust Vet J; 1981 Jan; 57(1):8-11. PubMed ID: 7236153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Babesia bovis: vaccination of cattle against heterologous challenge with fractions of lysate from infected erythrocytes.
    Goodger BV; Commins MA; Wright IG; Mirre GB
    Z Parasitenkd; 1984; 70(3):321-9. PubMed ID: 6429962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of pathophysiological reactions to assess the efficacy of the immune response to Babesia bovis in cattle.
    Goodger BV; Wright IG; Mahoney DF
    Z Parasitenkd; 1981; 66(1):41-8. PubMed ID: 6172907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Babesia bovis: successful vaccination against homologous challenge in splenectomised calves using a fraction of haemagglutinating antigen.
    Goodger BV; Wright IG; Waltisbuhl DJ; Mirre GB
    Int J Parasitol; 1985 Apr; 15(2):175-9. PubMed ID: 3997349
    [No Abstract]   [Full Text] [Related]  

  • 18. Babesia bovis--analysis and vaccination trial with the cryoprecipitable immune complex.
    Goodger BV; Waltisbuhl DJ; Wright IG; Mahoney DF; Commins MA
    Vet Immunol Immunopathol; 1987 Jan; 14(1):57-65. PubMed ID: 3103316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Babesia bovis: comparison of culture-derived parasites, non-living antigen and conventional vaccine in the protection of cattle against heterologous challenge.
    Timms P; Dalgliesh RJ; Barry DN; Dimmock CK; Rodwell BJ
    Aust Vet J; 1983 Mar; 60(3):75-7. PubMed ID: 6347164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine babesiosis: pathogenicity and heterologous species immunity of tick-borne Babesia bovis and B bigemina infections.
    Smith RD; Molinar E; Larios F; Monroy J; Trigo F; Ristic M
    Am J Vet Res; 1980 Dec; 41(12):1957-65. PubMed ID: 7212429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.